Viewing Study NCT02119468


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-02-24 @ 2:07 PM
Study NCT ID: NCT02119468
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2014-04-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 12267
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View